ArticleBMC cancer2014

Akt inhibitor MK-2206 promotes anti-tumor activity and cell death by modulation of AIF and Ezrin in colorectal cancer.

Ekta Agarwal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.